- Awareness about and willingness to use long|acting injectable pre ...🔍
- Willingness and preferences for long|acting injectable PrEP among ...🔍
- Willingness to take long|acting injectable pre|exposure prophylaxis ...🔍
- Willingness to use and preferences for long‐acting injectable PrEP ...🔍
- Awareness and willingness to use HIV oral pre|exposure ...🔍
- Preference for long|acting injectable for ART and PrEP among ...🔍
- Exploring preferences and decision|making about long|acting ...🔍
- Zero knowledge and high interest in the use of long|acting injectable ...🔍
Awareness about and willingness to use long|acting injectable pre ...
Awareness about and willingness to use long-acting injectable pre ...
In the Bangkok Tenofovir Study of oral pre-exposure prophylaxis (PrEP; TDF/FTC), adherence was poor. Long-acting injectable pre-exposure ...
Awareness about and willingness to use long-acting injectable pre ...
We sought to examine awareness about LAI-PrEP and factors associated with willingness to use LAI-PrEP in this understudied population.
Willingness and preferences for long-acting injectable PrEP among ...
Introduction Cabotegravir long-acting injectable HIV pre-exposure prophylaxis (LA-PrEP) was shown to be safe and effective in multiple clinical trials.
Awareness about and willingness to use long-acting injectable pre ...
Long-acting injectable formulations, in particular, have demonstrated acceptability among other groups of MSM and people who use drugs (85)(86)(87) (88) (89).
Willingness to take long-acting injectable pre-exposure prophylaxis ...
Evidence on the willingness of men who have sex with men (MSM) with oral pre-exposure prophylaxis (PrEP) experience, especially those with ...
Willingness to use and preferences for long‐acting injectable PrEP ...
Long-acting injectable (LAI) pre-exposure prophylaxis (PrEP) for HIV prevention was approved by the U.S. Food and Drug Administration in 2021.
Awareness and willingness to use HIV oral pre-exposure ... - PLOS
The common reasons reported by the respondent for choosing injectable PrEP were having experience with injection (27.1%), it taking a long interval between ...
Preference for long-acting injectable for ART and PrEP among ...
Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs. J Subst Abuse ...
Exploring preferences and decision-making about long-acting ...
Intramuscular cabotegravir for long-acting injectable HIV pre-exposure prophylaxis (i.e., LAI-PrEP) was approved by the U.S. FDA in 2021.
Zero knowledge and high interest in the use of long-acting injectable ...
Long-acting injectable pre-exposure prophylaxis (LAI-PrEP) is an effective prevention method against human immunodeficiency virus (HIV) ...
Willingness to use long-acting injectable PrEP among HIV-negative ...
About three-fifths (66.3%) of MSM were aware of PrEP, and only 3.9% of MSM had used PrEP before. The willingness to use LAI-PrEP among MSM was ...
Long-Acting Injectable Pre-Exposure Prophylaxis for Reducing Risk ...
Both qualitative and quantitative studies surveying PWID have reported a high degree of willingness among study participants to use long-acting injectable PrEP.
Interest in Long-Acting Injectable PrEP in a Cohort of Men Who have ...
Awareness of and willingness to use oral pre-exposure prophy- laxis for HIV prevention among HIV-serodiscordant heterosexual couples: a cross-sectional survey ...
The Potential of Long-Acting, Injectable PrEP, and Impediments to ...
Despite the considerable benefits, many of the same barriers impacting oral PrEP usage will likely hinder injectable PrEP uptake. Awareness and ...
Long-acting Injectable PrEP: A Scoping Review - Kirby Institute
Awareness about and willingness to use long-acting injectable pre- exposure prophylaxis (LAI-PrEP) among people who use drugs. J Subst Abuse Treat. 2020;117 ...
WHO recommends long-acting cabotegravir for HIV prevention
The World Health Organization (WHO) today released new guidelines for the use of long-acting injectable cabotegravir (CAB-LA) as pre
(PDF) Willingness to Use Long-acting Injectable Pre-exposure ...
Willingness to Use Long-acting Injectable Pre-exposure Prophylaxis Among Key Populations at a Large Hiv Prevention Clinic in Kampala, Uganda: a ...
Optimizing Uptake of Long-Acting Injectable Pre-exposure ...
We analyzed preferences for mode of administration, side-effects, monetary cost, and time cost using a conditional logit model and predicted ...
Long-Acting Injectable Drugs for HIV-1 Pre-Exposure Prophylaxis
To address this, the prescribing and administration of CAB-LA should be delegated to lower-level cadres after adequate training. This will increase the ...
Long-Acting HIV Prevention Tools
... long-acting injectable form of PrEP. (Learn more.) Implants ... The more of these actions you take, the safer you will be. To learn ...